TipRanks
Haemonetics Corp. (HAE)
NYSE:HAE
US Market
Want to see HAE full AI Analyst Report?

Haemonetics (HAE) Blogger Opinions & Sentiment

450 Followers

Blogger Sentiment

Bullish: 60.00%
Sector Average
Bullish
HAE Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bearish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
40% Investing
20% SeekingAlpha
20% Zacks
20% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Haemonetics Corporation (HAE) -- Strong Earnings and Growth Potential | Ariel Small Cap Value Q3 2026
GuruFocus
BTIG raises Haemonetics stock price target on CSL Plasma deal
Investing
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of HAE?
Seeking Alpha’s Grassroots Trading has a Neutral Sentiment.
    What do Motley Fool contributors think of HAE?
    Currently there's no blogger sentiment for HAE.
    What Is HAE’s Blogger Sentiment?
    HAE’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for HAE?
      The most recent blogger prediction for HAE was made by GuruFocus News, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          MEOBFMesoblast Limited
          CRSPCrispr Therapeutics AG
          ARGXArgenx Se
          REGNRegeneron
          PRNAFAlterity Therapeutics